Delivery Order SPE2DB22D3401-SPE2DB25FT5MS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,601.50 to AmerisourceBergen Drug Corp for the supply of Fosfomycin 3 GM sachets, an antibiotic pharmaceutical product. The contract was awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, and utilized firm fixed pricing under a non-set-aside, competitive procurement process. Performance of this delivery order is based in Conshohocken, Pennsylvania, the headquarters location of AmerisourceBergen Drug Corp,...
- The Defense Logistics Agency awarded a delivery order valued at $1,002.72 to AmerisourceBergen Drug Corp for the supply of Fosfomycin 3 GM sachets. This competitively awarded, firm fixed-price contract was executed on August 28, 2025, with an ultimate completion date of August 29, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,643.52 to AmerisourceBergen Drug Corp for the supply of Fosfomycin 3 GM sachets, an antibiotic medication. This competitive award, issued on September 16, 2025, represents a firm fixed-price delivery order with an ultimate completion date of September 17, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $21,445.91 to AmerisourceBergen Drug Corp for the supply of Fosfomycin 3 GM sachets, with performance in Conshohocken, Pennsylvania and completion targeted for September 15, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement executed on September 12, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corporation, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,287.23 firm fixed price delivery order is for the provision of 4,564,085,519 units of the antibiotic medication Fosfomycin 3 GM Sachets. The award is associated with a larger indefinite delivery contract (IDC)...
- This is a delivery order (SPE2DB22D3016|SPE2DB24FBFK9) awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp for the supply of 4,565,618,229 units of Fosfomycin 3 GM sachets. The contract has a ceiling value of $1,120.23 and is a firm fixed price contract. The period of performance extends through August 29, 2024. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Fosfomycin 3 GM sachets, a pharmaceutical product. The contract has a firm fixed price of $1,291.85 and a completion date of September 25, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these essential medical commodities to support military treatment facilities and federal healthcare providers nationwide. The contract is not set aside for...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $2,853.92 to Amerisourcebergen Drug Corporation for 3 grams fosfomycin sachets. Amerisourcebergen Drug Corporation will deliver the requested medical supplies to a location in Conshohocken, Pennsylvania by July 18, 2023 under the terms of the contract. As the prime contractor, Amerisourcebergen Drug Corporation will utilize its extensive distribution network to provide this critical...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FOSFOMYCIN 3 GM SACHETS, a pharmaceutical product, with a ceiling value of $1,296.00 and a period of performance through July 14, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,373.84 for Cefazolin 1 GM vials on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under the company's larger...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB25FT5MSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,128.26 to AmerisourceBergen Drug Corp for the supply of Fosfomycin 3 GM sachets, an antibiotic medication. The contract, which is non-set-aside and competitively awarded, carries a firm fixed price structure with an ultimate completion date of August 7, 2025, just one day after the award date of August 6, 2025. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This delivery order operates as a child contract under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military healthcare systems worldwide. The parent IDC serves as a global pharmaceutical support vehicle enabling the company to fulfill diverse medical commodity requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/6/25 |